2010 Company Financials: Orthopaedic and Spine

• Posted in Business Critical | June 30, 2011 | Comments (0)
• Tags: supplier, industry watch, earnings, device company, financial, market growth, company financials, sales, oem, vetalice, market, earning
• By: Julie A. Vetalice

Here are the remaining full-year performance highlights for select orthopaedic companies. We include 4Q10 revenue breakdowns where available, as well. Detail relates to full year, unless otherwise noted. Exhibit 1 displays growth by product segment.

Exhibit 1: Orthopaedic Sales1 Increases by Product Segment: 2010 vs. 2009

NOTES TO EXHIBIT 1

1. Orthopaedic products only; constant currency, pro forma growth
2. Includes biologics
3. ORTHOWORLD estimate for the quarter ended 11/30/10; excludes dental; trauma includes stimulators; spine includes stimulators and orthobiologics.
4. For the 12 months ended 1/31/11
5. Spine
6. Endoscopy (most of which is orthopaedic)
7. ORTHOWORLD estimates
8. Excludes "Other" (Aerospace)